Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2019-07-17

Original market date: See footnote 1

2009-01-26

Lot number: See footnote 2

B180057DA

Expiry date: See footnote 2

2020-02-29

Product name:

METOJECT

DIN:

02320045 Electronic product monograph is not available

Company:

MEDEXUS PHARMACEUTICALS INC.
35 Nixon Road, Unit 10
Bolton
Ontario
Canada L7E 1K1

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular ,  Intra-Arterial ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

10:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

L01BA01 METHOTREXATE

Active ingredient group (AIG) number:See footnote5

0107545004

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
METHOTREXATE (METHOTREXATE SODIUM) 15 MG / 1.5 ML
Version 4.0.3

"Page details"

Date modified: